Silence Therapeutics PLC
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.2% | +25.6% | -1.3% | -23.3% | +3.7% | +15.7% | +7.2% | +5.4% | +226.3% | -85.9% | +1.4% | – | |
| – | -60.9% | +173.6% | +0.6% | -25.2% | +10.6% | -19.9% | -23.9% | +21.6% | +187.0% | -66.4% | -46.5% | – | |
| – | -130.9% | – | – | -97.7% | -10,482.4% | – | -166.7% | – | -170.1% | – | – | – | |
| – | -95.0% | -99.9% | +8,499,900.0% | -42.4% | +13.8% | -92.8% | +1,100.0% | -93.8% | +1,733.3% | -100.0% | – | – | |
| – | -98.1% | -13,164.9% | -99.9% | +66,972.1% | – | -181.5% | -96.5% | – | -204.0% | – | +549.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -17.6% | +1,240.9% | -99.1% | +400.3% | -211.1% | – | -92.9% | -107.5% | -81.2% | -100.0% | – | – | |
| – | -116.4% | – | -105.8% | – | – | -261.9% | – | – | -275.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.